BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/6/2025 8:47:56 AM | Browse: 276 | Download: 769
Publication Name World Journal of Hepatology
Manuscript ID 100968
Country Pakistan
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Letter to the Editor
Article Title Hepatitis B virus infection and metabolic dysfunction associated steatotic liver disease: Rising pandemic with complex interaction
Manuscript Source Unsolicited Manuscript
All Author List Ammara A Majeed and Amna S Butt
ORCID
Author(s) ORCID Number
Amna S Butt http://orcid.org/0000-0002-7311-4055
Funding Agency and Grant Number
Corresponding Author Amna S Butt, Associate Professor, Department of Medicine, Aga Khan University Hospital, Stadium Road, Karachi 74800, Pakistan. amna.subhan@aku.edu
Key Words Chronic hepatitis B virus infection; Obesity; Metabolic syndrome; Liver fibrosis; Steatotic liver disease
Core Tip Advancements and explorations in the understanding of underlying pathophysiology of concomitant hepatitis B virus (HBV) infection and metabolic dysfunction associated steatotic liver disease (MASLD) facilitates clinicians in managing patients with this complex interaction. Studies have shown various relationships and interactions between MASLD and HBV infection. Concomitant HBV infection and MASLD can result in increased HBV surface diversity and increased HBV variants which can potentially impact liver disease progression. Further research is warranted to better understand the mechanisms and optimize treatment strategies in patients with hepatic steatosis and HBV infection.
Publish Date 2025-01-06 08:47
Citation

Majeed AA, Butt AS. Hepatitis B virus infection and metabolic dysfunction associated steatotic liver disease: Rising pandemic with complex interaction. World J Hepatol 2025; 17(1): 100968

URL https://www.wjgnet.com/1948-5182/full/v17/i1/100968.htm
DOI https://dx.doi.org/10.4254/wjh.v17.i1.100968
Full Article (PDF) WJH-17-100968-with-cover.pdf